http://www.rns-pdf.londonstockexchange.com/rns/7903A_1-2024-8-16.pdf
This Notice is sent to you as a shareholder of the
SciBeta HFE Japan Equity 6F EW UCITS ETF, a
sub- fund of FundLogic Alternatives plc. It is important and
requires your immediate attention. If you are in any doubt as to
the action to be taken, you should immediately consult your
stockbroker, solicitor or attorney or other professional advisor.
If you sold or otherwise transferred your holding in the SciBeta
HFE Japan Equity 6F EW UCITS ETF, please send this Notice to the
stockbroker or other agent through whom the sale or transfer was
effected for transmission to the purchaser or transferee.
This Notice has not been reviewed by the Central Bank of
Ireland and it is possible that changes hereto may be necessary to
meet the requirements of the Central Bank of Ireland. The Directors
are of the opinion that there is nothing contained in this Notice
nor in the proposals detailed herein that conflicts with the
regulations of the Central Bank of Ireland.
Defined terms have the same meaning
as described in the Company's prospectus dated 1 August 2022, as
amended (the "Prospectus") and the
supplement in respect of the Fund
dated 1 December 2023 (the "Supplement").
FundLogic Alternatives plc
70 Sir John Rogerson's Quay Dublin 2
Ireland
(an umbrella fund with
segregated liability between sub-funds)
16 August 2024
FundLogic Alternatives plc (the
"Company")
SciBeta HFE Japan Equity 6F EW UCITS ETF
(the "Fund")
Dear Shareholder
As a Shareholder in the Fund, we are writing to
inform you that the Directors have resolved to terminate the Fund,
with effect from 17 September 2024 (the "Effective Date").
This decision has been taken because the Fund's value
is below the minimum level detailed in the Prospectus, namely
US$50,000,000.
Shareholders may, in accordance with the conditions
set out in the Prospectus and the Supplement, redeem their shares
in the Fund on each Dealing Day prior to the Effective Date. Any
remaining Shareholders will have their shares in the Fund redeemed
at the applicable Net Asset Value per Share on the Effective Date.
The Fund may commence to liquidate its exposure prior to the
Effective Date and accordingly the Fund's exposure may
substantially, and increasingly as the Effective Date approaches,
consist of cash. Please note that the trading of Shares on the
secondary market will continue until the Effective Date or the date
at which all Shares are voluntarily redeemed prior to the Effective
Date.
Directors: Maurice Murphy, Simon O'Sullivan, Rowena Mallaghan (UK) and David
Haydon (UK)
Registered
Office: 70 Sir John Rogerson's Quay, Dublin 2, Ireland Companies
Registration Office Number 483770